Could a personalized vaccine help keep cancer from coming back? — and more UCLA media

The Washington Post reported on promising results from a phase 3 trial of a personalized mRNA vaccine designed to prevent melanoma from returning after surgery. “This is exciting,” said Dr. Antoni Ribas, professor of medicine at the David Geffen School of Medicine at UCLA and director of the UCLA Health Jonsson Comprehensive Cancer Center’s tumor immunology and immunotherapy Program.